porcin
reproduct
respiratori
syndrom
prr
econom
devast
viral
diseas
caus
heavi
loss
swine
industri
worldwid
mani
studi
shown
transient
deliveri
small
interf
rna
sirna
adenovirusmedi
rna
interfer
rnai
could
potenti
inhibit
porcin
reproduct
respiratori
syndrom
viru
prrsv
replic
vivo
vitro
appli
rnai
produc
transgen
tg
pig
constitut
express
prrsvspecif
sirna
deriv
small
hairpin
rna
shrna
first
evalu
sirna
express
found
gener
pig
confirm
stabl
transmiss
detect
express
protein
kinas
r
pkr
found
differ
among
tg
nontransgen
ntg
wildtyp
pig
lastli
gener
pig
includ
tg
ntg
piglet
challeng
tcid
highli
pathogen
porcin
reproduct
respiratori
syndrom
viru
hpprrsv
result
show
vivo
sirna
express
substanti
reduc
serum
hpprrsv
titer
increas
surviv
time
day
tg
pig
compar
ntg
control
data
suggest
rnaibas
genet
modif
might
use
breed
viralresist
livestock
stabl
sirna
express
complic
sirna
toxic
porcin
reproduct
respiratori
syndrom
prr
highli
contagi
diseas
one
devast
swine
industri
worldwid
prr
character
sever
reproduct
failur
gilt
respiratori
ill
pig
age
etiolog
agent
prr
viru
prrsv
member
famili
arterivirida
contain
linear
positivesens
singlestrand
rna
genom
transcript
use
uniqu
mechan
involv
discontinu
subgenom
synthesi
meulenberg
et
al
unpreced
high
fever
diseas
caus
hpprrsv
broke
china
spread
provinc
brought
fatal
case
tian
et
al
current
princip
method
control
prevent
prrsv
infect
vaccin
howev
vaccin
unabl
provid
potent
last
diseas
control
immun
evas
strategi
prrsv
heterogen
genom
thanawongnuwech
suradhat
rna
interfer
rnai
rnaguid
sequencespecif
process
small
interf
rna
sirna
induc
posttranscript
gene
silenc
rna
silenc
initi
recogn
antivir
mechan
protect
host
organ
rna
viral
infect
waterhous
et
al
mani
studi
confirm
antivir
immun
mediat
virusderiv
small
interf
rna
virna
plant
invertebr
although
virna
identifi
mammal
evolv
interferon
ifn
pathway
instead
ding
voinnet
demonstr
sirna
elicit
specif
intracellular
antivir
resist
may
therefor
valuabl
therapeut
tool
gitlin
et
al
henc
rnai
great
potenti
inhibit
rna
viral
replic
vitro
vivo
sinc
first
report
case
rnai
therapi
human
pathogen
respiratori
syncyti
viru
rsv
bitko
barik
mani
type
human
virus
success
target
includ
human
immunodefici
viru
type
coburn
cullen
hepat
c
viru
kronk
et
al
hepat
b
viru
mccaffrey
et
al
sever
acut
respiratori
syndrom
et
al
influenza
viru
ge
et
al
subsequ
mani
virus
infect
larg
farm
anim
also
chosen
therapi
target
foot
mouth
diseas
viru
chen
et
al
porcin
circoviru
viru
type
feng
et
al
porcin
endogen
retroviru
ramsoondar
et
al
prrsv
guo
et
al
recent
report
declar
sirna
transgenesi
could
confer
viral
infect
resist
pseudorabi
viru
prv
mice
danielcarli
et
al
although
shown
transient
deliveri
sirna
target
viral
gene
protect
suscept
cell
line
et
al
stabl
transgen
cell
line
present
stabl
inhibit
viru
zhou
et
al
recombin
adenovirusmedi
rnai
guard
anim
viral
challeng
remain
unclear
whether
transgenesi
sirna
pig
confer
perman
resist
prrsv
infect
previous
design
sirna
target
open
read
frame
orf
region
prrsv
show
target
strongest
virusinhibit
effect
cell
importantli
viral
yield
cell
lower
control
cell
bao
et
al
encod
nonstructur
protein
nsp
includ
nsp
play
key
role
initi
viral
replic
music
gagnon
base
previou
vitro
data
aim
present
studi
produc
transgen
anim
perpetu
express
challeng
anim
prrsv
report
gener
transgen
pig
stabl
sirna
express
two
gener
reduct
prrsv
viremia
observ
base
previou
find
bao
et
al
select
rnai
trigger
target
sequenc
nt
prrsv
rna
genom
doublestrand
ds
oligonucleotid
encod
anneal
insert
vector
clone
bamhihindiiilinear
plasmid
wuhan
genesil
biotechnolog
hubei
china
contain
human
promot
gener
fig
detail
vector
construct
describ
previou
studi
bao
et
al
fetal
pig
fibroblast
cell
line
landrac
pig
establish
cultur
describ
previous
zhang
et
al
fibroblast
cell
transfect
linear
shrnaexpress
construct
cultur
plate
h
cell
transfer
six
plate
select
medium
contain
gml
promega
select
week
antibioticresist
coloni
select
pool
plate
fortyeight
hour
later
half
cell
well
subject
pcr
use
primer
identifi
transgen
posit
clone
half
cell
frozen
later
use
somat
cell
nuclear
transfer
scnt
approxim
embryo
transfer
surrog
sow
five
sow
receiv
embryo
implant
clone
pig
deliv
natur
birth
approxim
day
gener
fertil
tg
sow
semen
wildtyp
pig
tg
founder
pig
offspr
identifi
polymeras
chain
reaction
pcr
analysi
genom
dna
deriv
ear
biopsi
two
set
primer
design
cover
integr
region
tg
founder
pig
confirm
southern
blot
analysi
plasmid
vector
serv
posit
control
copi
number
standard
number
insert
vector
dna
per
diploid
genom
equival
indic
correspond
amount
plasmid
load
well
calcul
accord
equat
l
length
plasmid
c
copi
number
standard
l
mean
diploid
genom
proper
amount
plasmid
ear
dna
sampl
g
digest
pvuii
electrophores
agaros
gel
follow
transfer
posit
charg
nylon
membran
roch
appli
scienc
mannheim
germani
membran
hybrid
adigoxigenin
dig
label
probe
bp
gener
pcr
use
follow
set
primer
plasmid
templat
roch
digpcr
dna
label
kit
hybrid
signal
detect
use
roch
dig
dna
label
detect
kit
accord
manufactur
instruct
determin
transgen
copi
number
ct
method
livak
schmittgen
use
compar
ct
valu
cycl
threshold
ct
ct
target
minu
ct
control
gene
tg
anim
sampl
unknown
transgen
copi
number
ct
valu
known
calibr
wildtyp
wt
pig
genom
dna
sampl
carri
singl
copi
myostatin
mstn
gene
use
calibr
determin
transgen
copi
number
tg
founder
pig
transgen
amplifi
use
ctgaag
specif
primer
quantit
realtim
pcr
qrtpcr
use
detect
copi
number
reaction
perform
plate
use
roch
lightcycl
system
lc
roch
basel
switzerland
amplif
perform
reaction
volum
contain
l
templat
dna
ngl
l
primer
l
power
sybr
green
mix
appli
biosystem
foster
citi
ca
usa
l
ddh
reaction
perform
use
follow
cycl
condit
c
min
cycl
c
c
c
follow
c
c
min
final
cycl
c
gener
melt
curv
standard
set
mixtur
repres
copi
plasmid
dna
ng
wt
pig
genom
dna
use
construct
standard
curv
determin
correl
ct
valu
ct
gene
minu
ct
mstn
log
n
valu
n
copi
number
transgen
use
custom
taqman
small
rna
assay
appli
biosystem
evalu
sirna
express
tg
pig
chen
et
al
blood
sampl
founder
collect
challeng
prrsv
anim
heart
liver
spleen
lung
tonsil
blood
obtain
sirna
detect
total
rna
purifi
use
mirvana
mirna
isol
kit
ambion
austin
tx
usa
revers
transcriptas
reaction
realtim
pcr
perform
accord
manufactur
protocol
gene
serv
intern
refer
control
realtim
pcr
gene
perform
way
sirna
express
normal
express
use
ct
method
ct
minu
ct
quantif
protein
kinas
r
pkr
ifnw
e
appli
qrtpcr
detect
pkr
express
tg
pig
whole
blood
rna
purifi
use
qiaamp
rna
blood
mini
kit
qiagen
hilden
germani
accord
manufactur
protocol
genom
dna
remov
use
dnase
qiagen
rna
g
reversetranscrib
firststrand
cdna
moloney
murin
leukemia
viru
transcriptas
promega
oligo
dt
primer
takara
bio
inc
shiga
japan
pcr
amplif
perform
use
l
rt
product
pkrand
primer
forward
pkr
primer
revers
pkr
primer
forward
primer
revers
pkr
primer
mrna
concentr
normal
glyceraldehyd
dehydrogenas
gapdh
forward
gapdh
primer
revers
gapdh
primer
anim
studi
perform
accord
protocol
approv
anim
welfar
committe
china
agricultur
univers
viral
challeng
perform
use
prrsv
isol
tian
et
al
highli
pathogen
strain
highli
pathogen
porcin
reproduct
respiratori
syndrom
hpprr
prrsv
variant
character
high
fever
high
mortal
tian
et
al
three
group
establish
tg
nontransgen
ntg
immun
control
ic
group
n
tg
group
n
ntg
group
n
ic
group
pig
month
old
pig
ic
group
vaccin
ml
modifiedl
prrsv
vaccin
ingelvac
prr
mlv
boehring
ingelheim
vetmedica
via
intramuscular
rout
day
viru
challeng
nonattenu
parent
viru
isol
minnesota
attenu
form
viru
commerci
avail
tradenam
ingelvac
prr
mlv
challeng
strain
homolog
tg
ntg
pig
gener
ie
offspr
founder
pig
tabl
viru
challeng
anim
tg
ntg
group
test
prrsv
neg
pcr
serolog
pig
receiv
ml
tcid
viru
appropri
dosag
vaccin
evalu
effect
infect
rectal
temperatur
record
daili
start
day
prior
challeng
necropsi
day
postinfect
day
postinfect
dpi
blood
sampl
collect
serum
sampl
test
use
commerci
prrsv
enzymelink
immunosorb
assay
elisa
idexx
laboratori
inc
westbrook
usa
assess
presenc
prrsv
antibodi
quantit
rtpcr
amplif
rna
perform
examin
prrsv
replic
pig
blood
use
quantitect
probe
rtpcr
kit
qiagen
oligonucleotid
primer
duallabel
probe
use
amplif
forward
revers
duallabel
tabl
mortal
viral
load
data
challeng
test
day
pig
tg
ntg
group
gener
tg
founder
ic
group
old
pig
vaccin
ingelvac
prr
mlv
pig
challeng
dpi
sampl
invalid
sampl
unavail
surviv
indic
length
green
bar
number
day
repres
estim
viral
titrat
blood
sampl
express
probe
correspond
base
pair
posit
genbank
access
number
construct
standard
curv
relat
viral
titer
sampl
express
tcid
ct
valu
obtain
qrtpcr
use
serial
dilut
viru
lysat
rang
tcid
data
shown
ct
valu
determin
amplif
plot
tcid
valu
pulmonari
alveolar
macrophag
pam
prepar
use
lung
lavag
techniqu
wensvoort
et
al
tg
pig
n
ntg
pig
n
confirm
pig
prrsvfree
qrtpcr
elisa
brief
lung
piglet
wash
time
hbss
hank
balanc
salt
solut
supplement
fetal
bovin
serum
eliquot
wash
fluid
centrifug
rpm
c
min
cell
pellet
resuspend
ml
medium
gibco
invitrogen
corpor
ca
contain
fetal
bovin
serum
unitsml
penicillin
gml
streptomycin
cell
concentr
pam
adjust
medium
contain
fetal
bovin
serum
ad
petri
dish
thermo
incub
h
c
humidifi
compart
adher
procedur
yield
approxim
pure
macrophag
determin
light
microscopi
pam
incub
h
c
co
medium
nonadher
cell
remov
gentl
wash
medium
inocul
cell
inocul
moi
collect
h
post
inocul
pi
respect
uninfect
cell
serv
mockinfect
cell
total
rna
infect
cell
isol
subject
qpcr
analysi
gapdh
serv
intern
control
ct
method
rel
quantit
gene
express
use
determin
viral
rna
level
ct
calcul
subtract
ct
gapdh
ct
viral
rna
ct
calcul
subtract
ct
refer
sampl
rna
tg
pam
pi
h
ct
sampl
fold
chang
gener
use
equat
ct
detect
prrsv
pam
immunofluoresc
assay
ifa
perform
pam
infect
prrsv
moi
h
cell
fix
cold
methanolaceton
min
c
wash
phosphatebuff
salin
pb
three
time
block
goat
serumpb
min
room
temperatur
cell
incub
monoclon
antibodi
mab
rural
technolog
prrsv
nucleocapsid
protein
rpm
h
wash
pb
three
time
cell
incub
alexa
fluor
goat
antimous
igg
antibodi
beyotim
institut
biotechnolog
rpm
h
wash
pb
cell
examin
fluoresc
microscopi
student
ttest
use
determin
signific
differ
among
group
pvalu
consid
statist
signific
nvalu
repres
number
independ
experi
given
outstand
perform
bao
et
al
produc
transgen
pig
harbor
sequenc
use
scnt
techniqu
fig
six
femal
tg
founder
pig
deriv
cell
clone
obtain
seven
newborn
piglet
preliminari
pcr
evid
express
cassett
fig
subsequ
perform
southern
blot
confirm
result
fig
transgen
copi
number
measur
realtim
pcr
shown
fig
ct
valu
ct
gene
minu
ct
mstn
sampl
plot
respect
log
n
valu
n
transgen
copi
number
accordingli
copi
number
insert
vector
calcul
roughli
consist
southern
blot
result
posit
tg
pig
insemin
artifici
wildtyp
semen
brought
offspr
femal
male
piglet
grew
healthili
one
month
old
tg
probabl
due
insuffici
nurs
abil
clone
sow
death
occur
first
day
surviv
grew
well
wildtyp
pig
custom
taqman
small
rna
assay
use
confirm
sirna
level
transgen
pig
sirna
product
normal
express
reportedli
abund
stabl
tissu
proven
suitabl
intern
control
jurcev
et
al
kiss
initi
examin
sirna
express
blood
founder
pig
need
keep
aliv
follow
propag
shown
fig
sirna
level
blood
transgen
pig
similar
around
normal
confirm
deriv
clone
mass
necropsi
six
tg
pig
sirna
level
lung
tonsil
liver
blood
spleen
heart
tissu
examin
ratio
rna
approxim
fig
result
founder
pig
show
sirna
level
close
among
individu
although
divers
among
differ
tissu
addit
sirna
level
blood
similar
founder
gener
pig
thu
sirna
express
stabli
transmit
least
one
gener
ifn
system
could
activ
sirna
pkr
necessari
induc
type
interferon
sledz
et
al
activ
ifn
pathway
major
contributor
offtarget
effect
sirna
mammalian
cell
kenworthi
et
al
regard
measur
pkr
realtim
pcr
blood
extract
tg
nontg
wt
pig
tg
nontg
pig
gener
ie
offspr
founder
shown
fig
signific
differ
level
pkr
among
three
group
p
indic
endogen
sirna
express
induc
type
ifn
respons
evalu
suscept
tg
pig
prrsv
infect
viral
challeng
administ
intramuscular
inject
hpprrsv
strain
tian
et
al
homolog
design
challeng
anim
includ
tg
group
five
pig
ntg
group
four
pig
ic
group
five
pig
tabl
shown
fig
prior
day
infect
anim
tg
ntg
group
test
posit
prrsv
postinfect
day
anim
exhibit
high
fever
trend
bodi
temperatur
similar
ntg
group
ic
headtohead
arrow
denot
primer
use
identifi
transgen
insert
tg
pig
two
pvuii
site
kb
apart
probe
posit
use
southern
blot
indic
b
pcr
detect
tg
mice
assess
integr
insert
two
end
transgen
amplifi
bp
bp
separ
tg
pig
genom
dna
use
specif
primer
two
pcr
product
length
bp
bp
identifi
end
end
insert
transgen
bp
dna
ladder
tg
founder
n
genom
dna
wt
pig
neg
control
p
posit
control
c
detect
transgen
integr
genom
southern
blot
analysi
sirna
express
cassett
insert
genom
indic
band
posit
control
vector
plasmid
electrophoresi
southern
blot
transfer
membran
probe
integr
vector
dna
copi
number
standard
number
insert
vector
dna
per
diploid
genom
equival
indic
standard
curv
number
transgen
correspond
ct
valu
qrtpcr
perform
determin
copi
number
transgen
standard
set
mixtur
includ
copi
plasmid
dna
ng
wt
pig
genom
dna
use
establish
standard
curv
axi
repres
ct
valu
ct
gene
minu
ct
mstn
x
axi
repres
ratio
transgen
copi
number
group
remain
elev
postinfect
day
decreas
bodi
temperatur
tg
pig
increas
slowli
first
dpi
climb
drastic
fig
might
suggest
sirna
work
earli
stage
prrsv
infect
averag
surviv
time
infect
calcul
group
result
show
tg
pig
exhibit
significantli
longer
surviv
time
day
ntg
pig
day
tg
ic
group
perform
similarli
fig
subsequ
quantifi
viral
genom
rna
prrsvspecif
antibodi
serum
infect
anim
blood
collect
anim
serolog
analysi
dpi
overal
trend
dynam
viremia
fig
analysi
sirna
express
transgen
pig
rna
isol
tg
founder
blood
small
rna
taqman
perform
express
sirna
express
rel
ratio
use
refer
gene
data
present
mean
sd
six
repeat
individu
b
necropsi
tg
pig
rna
sever
tissu
lung
tonsil
liver
blood
spleen
heart
isol
correspond
sirna
quantifi
data
present
mean
sd
six
tg
pig
fig
pkr
mrna
level
blood
tg
ntg
wildtyp
pig
pkr
mrna
level
determin
qrtpcr
blood
extract
describ
section
signific
differ
pkr
mrna
level
among
tg
ntg
wildtyp
pig
p
data
present
mean
sd
three
pig
group
infect
similar
anim
tg
ic
group
challeng
pig
viral
content
increas
dramat
immedi
infect
approxim
dpi
peak
meanwhil
serum
viral
load
ntg
group
underw
abrupt
decreas
anim
began
die
dpi
consist
surviv
time
data
lowest
viral
load
detect
ic
group
viral
load
tg
group
lower
ntg
group
fig
averag
viral
rna
load
serum
lower
tg
group
ntg
group
dpi
p
furthermor
prrsvspecif
antibodi
examin
use
herdchek
prr
elisa
idexx
inc
humor
immun
respons
prrsv
infect
show
pig
infect
viral
challeng
shown
fig
magnitud
antibodi
respons
ic
group
higher
unvaccin
pig
signific
differ
tg
ntg
group
p
suggest
pig
present
similar
immun
respons
sinc
viral
suppress
observ
tg
pig
next
analyz
prrsv
replic
infect
pam
target
cell
prrsv
teifk
et
al
sirna
express
tg
pam
examin
firstli
refer
rna
fig
cell
infect
intracellular
viral
replic
detect
viral
growth
suppress
pi
h
pi
h
compar
ntg
pam
pi
h
viral
rna
could
detect
due
cell
lysi
tg
pam
around
refer
sampl
fig
importantli
tg
pam
exhibit
appar
reliev
prrsvinduc
cytopathogen
effect
cpe
comparison
ntg
pam
fig
investig
effect
rna
interfer
prrsv
infect
appli
immunofluoresc
assay
detect
prrsv
pam
result
show
prrsv
infect
suppress
tg
pam
compar
ntg
pam
earli
stage
infect
pi
h
howev
differ
two
subject
becam
smaller
pi
h
fig
taken
togeth
transgen
sirna
inhibit
prrsv
replic
pam
tg
pig
li
et
al
report
adenovirusmedi
rnai
inhibit
prrsv
replic
swine
larg
proport
report
rnaibas
therapi
thu
far
evalu
viral
vector
see
review
davidson
mccray
howev
safeti
efficaci
rnai
challeng
signific
problem
stem
rectal
temperatur
three
group
tg
group
n
ntg
group
n
ic
group
n
measur
interv
sinc
day
infect
end
experi
b
surviv
curv
pig
prrsv
infect
pig
tgp
group
surviv
significantli
longer
ntg
group
day
respect
p
ic
group
day
c
viral
growth
curv
pig
three
group
serum
sampl
collect
indic
time
posttransfect
ct
valu
sampl
obtain
qrtpcr
correspond
valu
determin
accord
standard
curv
viral
load
tg
pig
significantli
higher
ntg
pig
dpi
p
p
antibodi
curv
three
group
specif
antibodi
prrsv
protein
measur
elisa
herdcheck
idexx
laboratori
indic
time
result
express
sp
ratio
averag
sp
ratio
consid
neg
differ
two
sp
ratio
tg
ic
signific
indic
time
p
data
panel
present
mean
se
statist
signific
analyz
use
studentstest
fig
transgen
sirna
pam
inhibit
prrsv
replic
qrtpcr
analysi
sirna
express
pam
isol
tg
pig
express
sirna
express
rel
ratio
data
present
mean
sd
three
tg
pig
b
qrtpcr
analysi
viral
rna
tg
ntg
pam
inocul
prrsv
h
fold
chang
gener
ct
ct
ct
viral
rna
ct
gapdh
ct
ct
ct
refer
viral
rna
pi
h
default
fold
viral
rna
pi
h
data
repres
result
three
individu
mean
sd
c
pam
tg
ntg
pig
observ
develop
cpe
brightfield
microscopi
h
pi
immunofluoresc
assay
analysi
prrsv
n
protein
tg
ntg
pam
infect
prrsv
h
host
cellular
humor
immun
respons
huang
yang
report
first
time
transgen
pig
harbor
rna
polymeras
iii
promot
drive
sirna
target
conserv
region
prrsv
genom
moreov
accord
similar
sirna
express
level
blood
two
gener
presum
sirna
express
founder
pig
similar
may
indic
reliabl
stabl
transgen
express
passag
need
demonstr
sustain
hered
sirna
express
porcin
alveolar
macrohphag
pam
primari
target
cell
prrsv
invad
teifk
et
al
rnai
effect
occur
could
play
major
role
viru
inhibit
result
qrtpcr
ifa
prrsvinfect
pam
confirm
integr
sirna
express
could
also
inhibitori
effect
viru
vitro
turn
prove
transgen
sirna
reduc
viral
load
blood
vivo
characterist
featur
rna
virus
arterivirus
high
mutat
rate
allow
adapt
escap
host
immun
respons
sinc
rnai
reli
perfect
match
sirna
target
sequenc
viral
rna
genom
even
singl
mutat
would
suffic
abolish
antivir
effect
sirna
du
et
al
avoid
viral
escap
rnai
given
former
work
cell
line
develop
select
target
conserv
region
prrsv
genom
among
sirna
target
orf
bao
et
al
gener
transgen
pig
highli
pathogen
prrsv
strain
genbank
access
number
use
refer
sequenc
studi
target
sequenc
locat
prrsv
genom
site
code
region
sequenc
highli
conserv
american
prrsv
strain
confirm
comparison
use
basic
local
align
search
tool
algorithm
nation
center
biotechnolog
inform
websit
wwwncbinlmnihgov
addit
encod
nsp
put
rnadepend
rna
polymeras
play
central
role
viral
replic
wang
et
al
although
mani
studi
report
rna
polymeras
iii
promot
induc
strong
express
sirna
other
found
rnai
vector
mammalian
cell
may
induc
distinct
ifn
respons
bridg
et
al
result
show
sirna
express
transgen
pig
low
signific
ifn
respons
detect
could
possibl
low
sirna
express
account
absenc
ifn
respons
posit
effect
effect
local
chromosom
environ
level
pattern
transgen
express
probabl
account
low
product
sirna
small
insert
dna
fragment
like
subject
effect
therefor
develop
new
transgen
technolog
improv
prrsv
specif
rnai
could
help
enhanc
antivir
capac
pig
artifici
microrna
xia
et
al
boudreau
et
al
nonetheless
stabli
express
sirna
still
block
prrsv
replic
extent
without
caus
visibl
toxic
review
clark
whitelaw
advent
new
method
rnai
advanc
transgen
livestock
research
thu
develop
transgen
anim
constitut
express
sirna
target
knockdown
pathogen
viru
transcript
product
expect
near
futur
present
studi
transgen
pig
abl
reduc
viral
load
blood
quantit
reduct
amount
serum
viral
load
may
impair
forward
transmiss
prr
previous
describ
lyall
et
al
even
though
awar
low
product
sirna
induc
moder
inhibit
prrsv
rnai
combin
transgen
technolog
offer
possibl
genet
engin
livestock
promot
resist
viral
infect
